---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-013281"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T07:33:02.495663+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ImmuCell reports net loss of $2.5M for 2022; second contamination event slows Q1 2023 production

## Summary
- Net loss of $2.5M ($0.32 per share) vs loss of $78k in 2021; gross margin fell to 41% from 45%.
- EBITDA dropped to $350k from $2.7M; cash decreased to $5.8M from $10.2M.
- Second contamination event detected in Q1 2023; production slowdown and backlog more than doubled since year-end.
- Deferred planned capacity expansion to over $40M/year due to lost gross margin in Q1 2023.
- Aiming to re-submit CMC Technical Section for Re-Tain to FDA in Q1 2023, subject to external lab results.

## SEC filing metadata
- accession: 0001213900-23-013281
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000121390023013281/0001213900-23-013281-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000121390023013281/ea174041-8k_immucell.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-013281
- JSON: https://secwatch.observer/filing/0001213900-23-013281.json
- Plain text: https://secwatch.observer/filing/0001213900-23-013281.txt

## Key facts
- Earnings Releases
  IMMUCELL CORP /DE/ reported financial results for the year ended December 31, 2022.
  - Period: the year ended December 31, 2022
  - Result: reported results
  source text: On February 21, 2023 ImmuCell Corporation (the "Company") issued a press release announcing the unaudited financial results for the year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390023013281/0001213900-23-013281-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.